GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Merck KGaA MRK.DE · EUR

Health Care · Pharmaceuticals · XETRA · 🇩🇪 Germany

DAX

Compare

149.20

+0.30%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Merck KGaA — daily XETR:MRK End of day
Market value
€64.82bn
Last close × shares
Volume
252.3k
Shares, 9 Nov 2026
Price to earnings
25.0
Dividend yield
1.46%

About Merck KGaA

Its shares trade on XETRA under the ticker MRK.DE. It has been listed since 20 October 1995. It is a member of the DAX. In the fiscal year to 31 December 2025, it reported revenue of €21.10bn and net income of €2.61bn. At that date it held total assets of €52.10bn and shareholders' equity of €28.59bn.

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. The company is headquartered in Darmstadt, Hessen. The firm operates in three business segments: Healthcare, Life Sciences and Performance Materials. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Performance Materials business provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.

Figures and description from our data supplier, not checked against the company's own report.

More about Merck KGaA →

Latest on Merck KGaA

Our reporting

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of 2.20 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Merck KGaA's ticker?

Merck KGaA trades as MRK.DE on XETRA, under ISIN DE0006599905.

What was Merck KGaA's last closing price?

149.20 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Merck KGaA next report results?

Results are expected on 12 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.